Daito Pharmaceutical has an EPS of $227.427273. In 2022, the company made an earnings per share (EPS) of $304.918182. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | $227.43 | -25.41% |
2022 | $304.92 | 7.84% |
2021 | $282.75 | 1.16% |
2020 | $279.49 | - |